Alliance Pharma (APH)

 

APH Share PerformanceMore

52 week high57.56 25/07/17
52 week low41.33 09/11/16
52 week change 7.50 (16.30%)
4 week volume11,395,469 29/08/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Alliance Pharma revenues and earnings rise

Alliance Pharma's revenues rose by 8% to 50.3m in the six months to the end of June. EBITDA increased by 3% to 13.6m an...

Interim Results

RNS Number: 5694Q Alliance Pharma PLC 13 September 2017 For immediate release 13 September 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Interim Results for the six months ended 30 June 2017 Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, is pleased to announce its interim results for the six months ended 30 June ...

Appointment of Joint Corporate Broker

RNS Number: 9074P Alliance Pharma PLC 06 September 2017 For immediate release 6 September 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Appointment of Joint Corporate Broker Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, is pleased to announce the appointment of Investec Bank plc as joint corporate broker to ...

Notification of Interim Results

RNS Number: 6570M Alliance Pharma PLC 01 August 2017 For immediate release 1 August 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Notification of Interim Results Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, will announce its interim results for the six months ended 30 June 2017 on Wednesday 13 September 201...

Broker Forecast - finnCap issues a broker note on Alliance Pharma PLC

finnCap today reaffirms its buy investment rating on Alliance Pharma PLC (LON:APH) and cut its price target to 58p (fr...

Update on Diclectin

RNS Number: 4885M Alliance Pharma PLC 28 July 2017 For immediate release 28 July 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Update on Diclectin Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, announces that it has been advised by the UK's regulator, the Medicines and Healthcare products Regulatory Agency (M...

Changes to interests of a significant shareholder

RNS Number: 0753M Alliance Pharma PLC 25 July 2017 For immediate release 25 July 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Changes to interests of a significant shareholder Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, has received a notification of a change in the interests of a significant shareholder. In accor...

Changes to interests of a significant shareholder

RNS Number: 0749M Alliance Pharma PLC 25 July 2017 For immediate release 25 July 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Changes to interests of a significant shareholder Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, has received a notification of a change in the interests of a significant shareholder. In accor...

Fundamental DataMore

P/E ratio13.896
EPS3.85
Dividend yield2.262 %

Equity Research (APH)

hardman & co
Alliance Pharma plc
24/07/2017
Alliance Pharma’s buy-and-build strategy to evolve into a profitable, cash generative, specialty pharma business is clearly bearing fruit. Acquisition of the dermatology and woundcare products from...
hardman & co
Alliance Pharma plc
25/05/2017
Alliance Pharma’s buy-and-build strategy to evolve into a profitable, cash generative, specialty pharma business is clearly bearing fruit. Acquisition of the dermatology and woundcare products from...
Alliance Pharma plc
01/02/2017
Early Equity (EEQP.NEX) 1.1p £7m FY Aug 16 results from the UK investment Company that provides equity and debt capital, along with strategic and operational counsel, to businesses that have the...

Latest discussion posts More

  • H1 Results

    H1 Results show steady sales progress and excellent cash flow. I do like APH's no-nonsense accounts, no sneaky hidden things, all facts honest & plain for all to see. I hold ...
    13-Sep-2017
    winningstreak
  • Re: Diclectin

    It's interesting - the drug is already approved in Canada and the FDAC but the MHRA rejected it. I wouldn't say it's written off just yet, but I'd like to hear why it was ...
    23-Aug-2017
    Ozonechemist
  • Re: Dropped again

    I will take a further look at OPG when there is substantial volume and it is above the moving averages.
    9-Aug-2017
    IAmShareCrazy

Users' HoldingsMore

Users who hold Alliance Pharma also hold..
LLOYDS GRP.31%
NATIONAL GRID20%
GLAXOSMITHKLINE19%
BP17%
HSBC HLDGS.UK15%

Codes & Symbols

ISINGB0031030819
SymbolsAPH, LSE:APH, APH.L, APH:LN, LON:APH, XLON:APH